TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 52 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Southpaw Asset Management LP | 20,000,000 | $17,613,000 | 24.41% |
| INCOME RESEARCH & MANAGEMENT | 15,589,000 | $13,663,000 | 3.91% |
| Fore Capital, LLC | 7,000,000 | $6,167,000 | 1.72% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 37,354,000 | $32,925,000 | 0.63% |
| CSS LLC/IL | 10,150,000 | $8,946,000 | 0.44% |
| Lombard Odier Asset Management (Europe) Ltd | 7,250,000 | $6,400,000 | 0.44% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 14,105,000 | $12,526,000 | 0.25% |
| OAKTREE CAPITAL MANAGEMENT LP | 15,820,000 | $13,944,000 | 0.22% |
| Wellesley Asset Management | 4,469 | $3,939,000 | 0.21% |
| AEGON USA Investment Management, LLC | 800,000 | $701,000 | 0.20% |